Johnson & Johnson buy tamam
Summary
This prediction ended on 05.11.21 with a price of €142.02. The BUY prediction by tamam finished with a performance of 18.45%. A total of €8.52 was paid as dividends for this prediction. tamam has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Johnson & Johnson | 3.448% | 3.448% | 0.367% | 0.551% |
iShares Core DAX® | -3.033% | 0.651% | 12.268% | 18.187% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% | 47.279% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% | 10.489% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% | 45.572% |
Comments by tamam for this prediction
In the thread Johnson & Johnson diskutieren
tamam stimmt der Buy-Einschätzung von Traumtanz zu
tamam stimmt am 14.12.2018 der Buy-Einschätzung von Traumtanz mit dem Kursziel 150$ zu.
Überschrift: Johnson & Johnson
In the thread Trading Johnson & Johnson